Bakhu Holdings, Corp. Reports Earnings Results for the Second Quarter Ended January 31, 2019
March 25, 2019 at 01:35 pm
Share
Bakhu Holdings, Corp. announced earnings results for the second quarter ended January 31, 2019. For the second quarter, the company announced net loss was USD 334 compared to USD 35,145 a year ago. Basic eps was USD 0 compared to basic loss per share of USD 0.14 a year ago. For the half year, operating loss was USD 122,002 compared to USD 108,616 a year ago. Net loss was USD 122,670 compared to USD 116,506 a year ago. Basic eps was USD 0 compared to basic loss per share of USD 0.45 a year ago.
Bakhu Holdings, Corp. is a development-stage company. The Company hold a license from Cell Science to plant cell-extraction and replication technology and related equipment, processes, and formulations (the Licensed Science), to produce, manufacture, and sell cannabis-related byproducts - sometimes referred to as cannabinoids in North America, Central America, and the Caribbean for medical, food additive, and recreational uses. The Company is focused on testing and commercializing cannabis plant cell-extraction and replication technologies under a technology license granted by Cell Science. It also intends to sublicense the Licensed Science to third party sub-licensees. The Company has not generated any revenue.
BAKHU HOLDINGS, CORP. 
